HER2 Positive Breast Neoplasms
2 clinical trials · Condition
◉ Watch HER2 Positive Breast Neoplasms
| Record | Firm | Date |
|---|---|---|
| A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors (NCT06157892) | Seagen, a wholly owned subsidiary of Pfizer | 2024-05-20 |
| A Safety Study of SGN-LIV1A in Breast Cancer Patients (NCT01969643) | Seagen Inc. | 2013-10-22 |
Track HER2 Positive Breast Neoplasms automatically
Every clearance here is in the API, with alerts when new ones post.